MARROSU, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 362.270
NA - Nord America 23.377
AS - Asia 8.249
SA - Sud America 1.267
Continente sconosciuto - Info sul continente non disponibili 658
AF - Africa 169
OC - Oceania 37
Totale 396.027
Nazione #
IT - Italia 356.468
US - Stati Uniti d'America 22.890
SG - Singapore 3.128
CN - Cina 3.066
UA - Ucraina 1.418
SE - Svezia 1.173
BR - Brasile 1.017
DE - Germania 772
FI - Finlandia 732
VN - Vietnam 663
GB - Regno Unito 581
FR - Francia 483
HK - Hong Kong 282
CA - Canada 281
IN - India 196
KR - Corea 149
NL - Olanda 143
BD - Bangladesh 132
JP - Giappone 92
AR - Argentina 87
RU - Federazione Russa 85
IQ - Iraq 83
MX - Messico 63
PL - Polonia 63
PK - Pakistan 60
ES - Italia 57
TR - Turchia 57
AT - Austria 43
UZ - Uzbekistan 42
CH - Svizzera 41
BE - Belgio 39
IR - Iran 36
ZA - Sudafrica 36
ID - Indonesia 33
MA - Marocco 33
CO - Colombia 32
IE - Irlanda 32
VE - Venezuela 31
EC - Ecuador 30
AU - Australia 29
PH - Filippine 27
CR - Costa Rica 24
JM - Giamaica 24
AE - Emirati Arabi Uniti 23
EU - Europa 22
SA - Arabia Saudita 22
AZ - Azerbaigian 21
KE - Kenya 21
CL - Cile 20
IL - Israele 20
CZ - Repubblica Ceca 17
JO - Giordania 17
TN - Tunisia 17
PY - Paraguay 16
TH - Thailandia 15
GT - Guatemala 14
LT - Lituania 14
MY - Malesia 14
BO - Bolivia 13
CU - Cuba 13
HN - Honduras 11
PT - Portogallo 11
SV - El Salvador 11
UY - Uruguay 11
CW - ???statistics.table.value.countryCode.CW??? 10
EE - Estonia 10
RO - Romania 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
NI - Nicaragua 9
SI - Slovenia 9
DZ - Algeria 8
EG - Egitto 8
LB - Libano 8
MD - Moldavia 8
PA - Panama 8
PE - Perù 8
DK - Danimarca 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
OM - Oman 7
GR - Grecia 6
HR - Croazia 6
HU - Ungheria 6
KZ - Kazakistan 6
LK - Sri Lanka 6
MU - Mauritius 6
AL - Albania 5
GE - Georgia 5
LU - Lussemburgo 5
NG - Nigeria 5
NP - Nepal 5
AO - Angola 4
BY - Bielorussia 4
MK - Macedonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
CY - Cipro 3
Totale 395.342
Città #
Cagliari 349.016
Uta 5.169
Ashburn 3.239
Fairfield 1.686
Woodbridge 1.597
Singapore 1.485
Chandler 1.412
San Jose 1.372
Houston 1.005
Boardman 911
Ann Arbor 865
Dallas 860
Wilmington 778
Nyköping 761
Jacksonville 730
Seattle 649
Beijing 587
Dearborn 568
Cambridge 546
Helsinki 480
Los Angeles 377
New York 324
Santa Clara 305
Nanjing 287
Council Bluffs 286
Lauterbourg 234
Hong Kong 232
Munich 223
Shanghai 222
Rome 220
The Dalles 217
Boston 208
Milan 208
Hefei 195
Ho Chi Minh City 191
São Paulo 181
Buffalo 146
Hanoi 138
Seoul 137
Toronto 134
San Diego 116
Shenyang 103
Guangzhou 91
Orem 91
Nanchang 87
Redwood City 78
Chicago 72
Dong Ket 72
Hebei 72
London 72
Atlanta 68
Jiaxing 68
Tianjin 64
Verona 63
Changsha 59
Norwalk 59
Phoenix 58
San Francisco 56
Frankfurt am Main 51
Montreal 50
Sassari 50
Tokyo 49
Brooklyn 47
Warsaw 47
Redondo Beach 44
Mountain View 42
Jinan 41
Chennai 40
Denver 37
Naples 37
Tashkent 37
Washington 37
Brussels 36
Da Nang 36
Stockholm 36
Orange 34
Amsterdam 33
Rio de Janeiro 32
Carrboro 31
Columbus 30
Wuhan 30
Zhengzhou 30
Baghdad 29
Kunming 29
Manchester 28
Ningbo 28
North Bergen 28
Pune 28
Haiphong 27
Florence 25
Leawood 25
Nuremberg 25
Dublin 24
Turin 24
Mumbai 23
Auburn Hills 22
Bologna 22
Hangzhou 22
Porto Alegre 22
San Mateo 22
Totale 380.920
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.450
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.097
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.043
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.805
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS 4.339
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.305
PROP bitter taste-induced brain activation-deactivation in gustatory signal processing: a functional magnetic resonance imaging (fMRI) study 4.240
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.100
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.060
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.974
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.893
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.755
Impaired sense of smell in a Drosophila Parkinson's model. 3.689
Brain activation pattern during perception of PROP bitter taste using functional magnetic resonance imaging (fMRI) 3.566
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.559
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.527
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.487
The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond to VNS 3.451
F-Wave duration as a specific and sensitive tool for the diagnosis of restless legs syndrome/Willis-Ekbom disease 3.440
VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy 3.418
Parkinsonism and dementia are negative prognostic factors for the outcome of subdural hematoma 3.289
A multimodal neuroimaging approach in patients with early diagnosis of Parkinson's disease: Correlations between f-MRI with fine motor tasks, EEG and clinical tests 3.282
EEG functional network topology is associated with disability in patients with amyotrophic lateral sclerosis 3.253
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.190
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.186
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.135
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.984
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.974
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.961
Involvement of GABA in mirror focus: A case report 2.957
Functional brain connectivity analysis in amyotrophic lateral sclerosis: an EEG source-space study 2.933
Influence of parkinsonism on Hitler's decision-making 2.924
The effect of epoch length on estimated EEG functional connectivity and brain network organisation 2.858
VGF peptides as novel biomarkers in Parkinson’s disease 2.850
Polimorfismo Val66Met e valori di BDNF in pazienti affetti da epilessia farmacoresistente trattati con stimolazione del nervo vago (VNS). 2.822
Imaging and Genomic Classification of Brain Alteration Induced By Gustatory Bitter Stimulus, A Pilot Study 2.745
Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients 2.739
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.692
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.685
New vistas on VNS mechanism of action 2.627
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.621
Overlap Parasomnia Disorder in a case of Creutzfeldt-Jakob Disease 2.607
Reduction of fat mass by vagus nerve stimulation in rats 2.588
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 2.576
Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats 2.568
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.507
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.461
Clinical and genetic characteristics of late-onset Huntington's disease 2.434
Graph theory-based analysis of EEG during nREM sleep reveals changes in functional connectivity in sleep-related hypermotor epilepsy (SHE) 2.423
null 2.394
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.389
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.377
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.358
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.350
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.322
Clinical manifestations of intermediate allele carriers in Huntington disease 2.304
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED 2.246
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.245
Sleep motor activity in amyotrophic lateral sclerosis 2.218
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.214
Effects of vagus nerve stimulation on BDNF gene expression and hippocampal plasticity in the rat 2.200
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.200
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus 2.169
Neuroimaging, Networking and Systems Biology: The New Way to Investigate Pathologies with Neurological System Implications. The example of Tourette Syndrome as a Pilot Study 2.169
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.167
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 2.138
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.132
Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation 2.129
How individual habits fit/unfit social norms: from the historical perspective to a neurobiological repositioning of an unresolved problem 2.096
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.080
Assessment of heart rate variability in a population of Sardinian patients affected by amyotrophic lateral sclerosis 2.069
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.039
A multivariate approach for the brain impairment in patients with liver cirrhosi 2.022
Chronic effects of vagus nerve stimulation on body fat mass in the rat 1.999
Reduction in rat body weight and fat mass without affecting food intake induced by vagus nerve stimulation 1.984
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.938
ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis 1.928
null 1.926
Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis 1.920
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.906
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.901
Loss of heart rate variability in ALS: Time and frequency domain assessment. 1.901
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.894
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.885
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.880
Dissociation Between Neurovegetative Signs and Subjective Symptoms in a Case of Idiopathic Pilomotor Seizures 1.856
Role of DA-ergic therapy on REM sleep behaviour disorder in a large population of Parkinsonians 1.839
EEG spectral coherence analysis in nocturnal epilepsy 1.831
Spectral coherence analysis in EEG nocturnal epilepsy recordings 1.819
Lack of antidepressant like behavioral effects of chronic vagus nerve stimulation in the rat despite neurochemical end molecular antidepressant like effects 1.808
Long-latency potential study in minimal hepatic hencephalopaty 1.794
Respiratory sleep disorders in Jeune syndrome: a case description 1.767
Facial synkinesis as a first symptom of multiple sclerosis 1.760
Motor sleep features in a Sardinian population of amyotrophic lateral sclerosis patients. 1.721
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.706
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.704
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.664
Long term vagus nerve stimulation (VNS) modifies EEG coherences and frequency power spectrum in partial epilepsy 1.659
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.645
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.615
Totale 265.346
Categoria #
all - tutte 511.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 511.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.466 0 0 0 0 1.687 1.290 929 845 1.349 1.629 1.749 1.988
2022/202322.973 2.139 3.064 2.767 2.045 1.897 2.202 1.185 1.859 1.392 1.404 1.886 1.133
2023/202423.308 1.418 1.098 1.041 1.628 2.416 3.625 3.391 1.643 1.066 1.732 2.049 2.201
2024/202536.739 6.047 8.461 4.798 4.104 4.331 2.595 3.373 391 811 571 506 751
2025/202615.295 908 623 1.648 1.348 1.312 1.464 2.208 1.038 1.369 1.699 917 761
2026/20275.365 716 636 1.524 2.423 66 0 0 0 0 0 0 0
Totale 396.027